Background/Aims: The term trachyonychia, also known as twenty-nail dystrophy, is used to describe thin, brittle nails with excessive longitudinal ridging. The term twenty-nail dystrophy has been incorrectly applied to other conditions that can affect all twenty nails. Therefore, we have conducted a comprehensive review of the clinical features of trachyonychia and have included a discussion regarding the diagnostic accuracy of this condition in the literature. Methods: In November and December 2015, we conducted a thorough literature search using the following search terms: ‘trachyonychia', ‘twenty nail dystrophy', and ‘sandpaper nails'. Articles that reported the epidemiology, disease associations, clinical presentation, histopathology, and treatment options for trachyonychia were included. Particular attention was given to case reports to identify misdiagnosed cases of twenty-nail dystrophy. Results: Our preliminary search yielded 184 results with 72 unique articles ultimately selected for review. Excluded articles included 27 articles in languages other than English, 18 commentaries or reviews, and 67 irrelevant articles. Twelve additional articles described nail abnormalities clinically different from trachyonychia. Conclusion: Many other conditions can cause widespread nail dystrophy. The specific characteristics of trachyonychia need to be considered to make the diagnosis of twenty-nail dystrophy.

Keywords:
Trachyonychia, Twenty-nail dystrophy, Sandpaper nails
1.
Alkiewicz J: Trachyonychia. Ann Dermatol Venereol 1950;10:136-140.
2.
Hazelrigg DE, Duncan WC, Jarratt M: Twenty-nail dystrophy of childhood. Arch Dermatol 1977;113:73-75.
3.
Tosti A, Fanti PA, Morelli R, Bardazzi F: Trachyonychia associated with alopecia areata: a clinical and pathologic study. J Am Acad Dermatol 1991;25:266-270.
4.
Tosti A, Piraccini BM, Iorizzo M: Trachyonychia and related disorders: evaluation and treatment plans. Dermatol Ther 2002;15:121-125.
5.
Fernandez-Flores A, Castanon-Gonzalez JA, Guerrero-Ramos B, Castro-Gaytan A, Saeb-Lima M: Systemic amyloidosis presenting with glans penis involvement. J Cutan Pathol 2014;41:791-796.
6.
Braun-Falco O, Dorn M, Neubert U, Plewig G: Trachyonychia: 20-nail dystrophy (in German). Hautarzt 1981;32:17-22.
7.
Lau YM, Lam YK, Leung KH, Lin SY: Trachyonychia in a patient with chronic myeloid leukaemia after imatinib mesylate. Hong Kong Med J 2014;20:464.e2.
8.
Chen W, Yu YS, Liu YH, Sheen JM, Hsiao CC: Nail changes associated with chemotherapy in children. J Eur Acad Dermatol Venereol 2007;21:186-190.
9.
Germain-Lee EL, Zinkham WH: Twenty-nail dystrophy associated with hematologic abnormalities. Acta Paediatr Scand 1991;80:977-980.
10.
Taniguchi S, Kutsuna H, Tani Y, Kawahira K, Hamada T: Twenty-nail dystrophy (trachyonychia) caused by lichen planus in a patient with alopecia universalis and ichthyosis vulgaris. J Am Acad Dermatol 1995;33:903-905.
11.
James WD, Odom RB, Horn RT: Twenty-nail dystrophy and ichthyosis vulgaris. Arch Dermatol 1981;117:316.
12.
Nieves DS, Phipps RP, Pollock SJ, et al: Dermatologic and immunologic findings in the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. Arch Dermatol 2004;140:466-472.
13.
Leong AB, Gange RW, O'Connor RD: Twenty-nail dystrophy (trachyonychia) associated with selective IgA deficiency. J Pediatr 1982;100:418-420.
14.
Scardamaglia L, Howard A, Sinclair R: Twenty-nail dystrophy in a girl with incontinentia pigmenti. Australas J Dermatol 2003;44:71-73.
15.
Cahali JB, Kakuda EY, Santi CG, Maruta CW: Nail manifestations in pemphigus vulgaris. Rev Hosp Clin Fac Med Sao Paulo 2002;57:229-234.
16.
Sowden JM, Cartwright PH, Green JR, Leonard JN: Isolated lichen planus of the nails associated with primary biliary cirrhosis. Br J Dermatol 1989;121:659-662.
17.
Pucevich B, Spencer L, English JC 3rd: Unilateral trachyonychia in a patient with reflex sympathetic dystrophy. J Am Acad Dermat 2008;58:320-322.
18.
Aranegui B, Garcia-Cruz A, de la Torre C, Gonzalez-Valladares MG: Trachyonychia and sarcoidosis. J Am Acad Dermatol 2010;63:159-160.
19.
Blanco FP, Scher RK: Trachyonychia: case report and review of the literature. J Drugs Dermatol 2006;5:469-472.
20.
Khandpur S, Bansal A, Sharma VK, Bhatti SS, Singh MK: Twenty nail dystrophy in vitiligo. J Dermatol 2007;34:189-192.
21.
Rajashekar TS, Singh G, Rajkumar V: Segmental vitiligo and twenty-nail dystrophy: an unusual association. Indian J Dermatol Venereol Leprol 2008;74:661-662.
22.
Peloro TM, Pride HB: Twenty-nail dystrophy and vitiligo: a rare association. J Am Acad Dermatol 1999;40:488-490.
23.
Que SK, Sloan B, Dadras SS: Trachyonychia, cutis laxa, and easy bruising of the skin. Amyloidosis. JAMA Dermatol 2014;150:1357-1358.
24.
Peluso AM, Tosti A, Piraccini BM, Cameli N: Lichen planus limited to the nails in childhood: case report and literature review. Pediatr Dermatol 1993;10:36-39.
25.
Tosti A, Piraccini BM, Cambiaghi S, Jorizzo M: Nail lichen planus in children: clinical features, response to treatment, and long-term follow-up. Arch Dermatol 2001;137:1027-1032.
26.
Baran R, Dupre A, Christol B, Bonafe JL, Sayag J, Ferrere J: Vertical striated sand-papered twenty-nail dystrophy (in French). Ann Dermatol Venereol 1978;105:387-392.
27.
Tosti A, Bardazzi F, Piraccini BM, Fanti PA: Idiopathic trachyonychia (twenty-nail dystrophy): a pathological study of 23 patients. Br J Dermatol 1994;131:866-872.
28.
Gordon KA, Vega JM, Tosti A: Trachyonychia: a comprehensive review. Indian J Dermatol Venereol Leprol 2011;77:640-645.
29.
Grover C, Khandpur S, Reddy BS, Chaturvedi KU: Longitudinal nail biopsy: utility in 20-nail dystrophy. Dermatol Surg 2003;29:1125-1129.
30.
Jerasutus S, Suvanprakorn P, Kitchawengkul O: Twenty-nail dystrophy. A clinical manifestation of spongiotic inflammation of the nail matrix. Arch Dermatol 1990;126:1068-1070.
31.
Kanwar AJ, Ghosh S, Thami GP, Kaur S: Twenty-nail dystrophy due to lichen planus in a patient with alopecia areata. Clin Experiment Dermatol 1993;18:293-294.
32.
Sakata S, Howard A, Tosti A, Sinclair R: Follow-up of 12 patients with trachyonychia. Australas J Dermatol 2006;47:166-168.
33.
Tosti A, Bellavista S, Iorizzo M, Vincenzi C: Occupational trachyonychia due to psoriasis: report of a case successfully treated with oral acitretin. Contact Dermatitis 2006;54:123-124.
34.
Soda R, Diluvio L, Bianchi L, Chimenti S: Treatment of trachyonychia with tazarotene. Clin Exp Dermatol 2005;30:301-302.
35.
Schissel DJ, Elston DM: Topical 5-fluorouracil treatment for psoriatic trachyonychia. Cutis 1998;62:27-28.
36.
Park JM, Cho HH, Kim WJ, et al: Efficacy and safety of calcipotriol/betamethasone dipropionate ointment for the treatment of trachyonychia: an open-label study. Ann Dermatol 2015;27:371-375.
37.
Arias-Santiago S, Fernandez-Pugnaire MA, Husein El-Ahmed H, Giron-Prieto MS, Naranjo Sintes R: A 9 year-old child with trachyonychia: a good response with nail plate dressings (in Spanish). An Pediatr (Barc) 2009;71:476-477.
38.
Khandpur S, Reddy BS: An association of twenty-nail dystrophy with vitiligo. J Dermatol 2001;28:38-42.
39.
Khoo BP, Giam YC: A pilot study on the role of intralesional triamcinolone acetonide in the treatment of pitted nails in children. Singapore Med J 2000;41:66-68.
40.
Grover C, Bansal S, Nanda S, Reddy BS: Efficacy of triamcinolone acetonide in various acquired nail dystrophies. J Dermatol 2005;32:963-968.
41.
Halkier-Sorensen L, Cramers M, Kragballe K: Twenty-nail dystrophy treated with topical PUVA. Acta Derm Venereol 1990;70:510-511.
42.
Möhrenschlager M, Schmidt T, Ring J, Abeck D: Recalcitrant trachyonychia of childhood: response to daily oral biotin supplementation: report of two cases. J Dermatol Treat 2000;11:113-115.
43.
Lee YB, Cheon MS, Eun YS, Cho BK, Park YG, Park HJ: Cyclosporin administration improves clinical manifestations and quality of life in patients with 20-nail dystrophy: case series and survey study. J Dermatol 2012;39:1064-1065.
44.
Pierard GE, Pierard-Franchimont C: Dynamics of psoriatic trachyonychia during low-dose cyclosporin A treatment: a pilot study on onychochronobiology using optical profilometry. Dermatology 1996;192:116-119.
45.
Mittal R, Khaitan BK, Sirka CS: Trachyonychia treated with oral mini pulse therapy. Indian J Dermatol Venereol Leprol 2001;67:202-203.
46.
Evans AV, Roest MA, Fletcher CL, Lister R, Hay RJ: Isolated lichen planus of the toe nails treated with oral prednisolone. Clin Exp Dermatol 2001;26:412-414.
47.
Dhayalan A, King BA: Tofacitinib citrate for the treatment of nail dystrophy associated with alopecia universalis. JAMA Dermatol 2015;1-2.
48.
Tonolli VM, Stolf HO, Tonello CS, Pires RB, Abbade LP: Syndrome in question. Hay-Wells syndrome. An Bras Dermatol 2014;89:363-364.
49.
Gupta R, Mehta S, Pandhi D, Singal A: Hereditary punctate palmoplantar keratoderma (PPK) (Brauer-Buschke-Fischer syndrome). J Dermatol 2004;31:398-402.
50.
Kim G, Shin H: Rapp-Hodgkin syndrome. Dermatol Online J 2004;10:23.
51.
Dogruk Kacar S, Ozuguz P, Polat S: Coexistence of psoriasis, and alopecia areata with trachyonychia in a pediatric patient with Turner Syndrome. Arch Argent Pediatr 2014;112:e209-e212.
52.
Rai VM, Shenoi SD: Ichthyosis follicularis with congenital atrichia, nail dystrophy and palmoplantar keratoderma. Variant of IFAP syndrome or a new entity? Dermatol Online J 2005;11:36.
53.
Lee YB, Cheon MS, Eun YS, Park HJ, Cho BK: Elkonyxis in association with washboard nail and 20-nail dystrophy. Int J Dermatol 2014;53:e11-e13.
54.
Yokozeki H, Niiyama S, Nishioka K: Twenty-nail dystrophy (trachyonychia) caused by lichen planus in a patient with gold allergy. Br J Dermatol 2005;152:1087-1089.
55.
Tosti A, Morelli R, Bardazzi F, Peluso AM: Prevalence of nail abnormalities in children with alopecia areata. Pediatr Dermatol 1994;11:112-115.
56.
Tosti A, Ghetti E, Piraccini BM, Fanti PA: Lichen planus of the nails and fingertips. Eur J Dermatology 1998;8:447-448.
57.
Reich K: Approach to managing patients with nail psoriasis. J Eur Acad Dermatol Venereol 2009;23(suppl 1):15-21.
58.
Shim JH, Oh SH, Jun JY, Kim JH, Park JH, Lee DY: Trachyonychia as the presenting sign of myeloma-associated amyloidosis. Int J Dermatol 2016, Epub ahead of print.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.